BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tarry-Adkins JL, Aiken CE, Ozanne SE. Comparative impact of pharmacological treatments for gestational diabetes on neonatal anthropometry independent of maternal glycaemic control: A systematic review and meta-analysis. PLoS Med 2020;17:e1003126. [PMID: 32442232 DOI: 10.1371/journal.pmed.1003126] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Herath MP, Beckett JM, Hills AP, Byrne NM, Ahuja KDK. Gestational Diabetes Mellitus and Infant Adiposity at Birth: A Systematic Review and Meta-Analysis of Therapeutic Interventions. J Clin Med 2021;10:835. [PMID: 33670645 DOI: 10.3390/jcm10040835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Jones D, De Lucia Rolfe E, Rennie KL, Griep LMO, Kusinski LC, Hughes DJ, Brage S, Ong KK, Beardsall K, Meek CL. Antenatal Determinants of Childhood Obesity in High-Risk Offspring: Protocol for the DiGest Follow-Up Study. Nutrients 2021;13:1156. [PMID: 33807319 DOI: 10.3390/nu13041156] [Reference Citation Analysis]
3 Roy A, Sahoo J. Long-term effects of metformin use in gestational diabetes mellitus on offspring health. World J Diabetes 2021; 12(11): 1812-1817 [PMID: 34888009 DOI: 10.4239/wjd.v12.i11.1812] [Reference Citation Analysis]
4 Tarry-Adkins JL, Ozanne SE, Aiken CE. Impact of metformin treatment during pregnancy on maternal outcomes: a systematic review/meta-analysis. Sci Rep 2021;11:9240. [PMID: 33927270 DOI: 10.1038/s41598-021-88650-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Bovbjerg ML, Misra D, Snowden JM. Current Resources for Evidence-Based Practice, November 2020. J Obstet Gynecol Neonatal Nurs 2020;49:605-19. [PMID: 33096044 DOI: 10.1016/j.jogn.2020.10.001] [Reference Citation Analysis]
6 Dumolt JH, Powell TL, Jansson T. Placental Function and the Development of Fetal Overgrowth and Fetal Growth Restriction. Obstet Gynecol Clin North Am 2021;48:247-66. [PMID: 33972064 DOI: 10.1016/j.ogc.2021.02.001] [Reference Citation Analysis]
7 Simmons R. Metformin in pregnancy: a re-examination of its safety. J Physiol 2021. [PMID: 34762307 DOI: 10.1113/JP282324] [Reference Citation Analysis]
8 Hufnagel A, Fernandez-Twinn DS, Blackmore HL, Ashmore TJ, Heaton RA, Jenkins B, Koulman A, Hargreaves IP, Aiken CE, Ozanne SE. Maternal but not fetoplacental health can be improved by metformin in a murine diet-induced model of maternal obesity and glucose intolerance. J Physiol 2021. [PMID: 34505282 DOI: 10.1113/JP281902] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Dearden L, Bouret SG, Ozanne SE. Nutritional and developmental programming effects of insulin. J Neuroendocrinol 2021;33:e12933. [PMID: 33438814 DOI: 10.1111/jne.12933] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Owen MD, Baker BC, Scott EM, Forbes K. Interaction between Metformin, Folate and Vitamin B12 and the Potential Impact on Fetal Growth and Long-Term Metabolic Health in Diabetic Pregnancies. Int J Mol Sci 2021;22:5759. [PMID: 34071182 DOI: 10.3390/ijms22115759] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M; American Diabetes Association Professional Practice Committee., American Diabetes Association Professional Practice Committee:. 15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S232-43. [PMID: 34964864 DOI: 10.2337/dc22-S015] [Reference Citation Analysis]
12 Aye ILMH, Aiken CE, Charnock-Jones DS, Smith GCS. Placental energy metabolism in health and disease-significance of development and implications for preeclampsia. Am J Obstet Gynecol 2020:S0002-9378(20)31287-4. [PMID: 33189710 DOI: 10.1016/j.ajog.2020.11.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Mirabelli M, Chiefari E, Tocci V, Greco E, Foti D, Brunetti A. Gestational diabetes: Implications for fetal growth, intervention timing, and treatment options. Curr Opin Pharmacol 2021;60:1-10. [PMID: 34280703 DOI: 10.1016/j.coph.2021.06.003] [Reference Citation Analysis]
14 Koufakis T, Garas A, Zebekakis P, Kotsa K. Non-insulin agents for the management of gestational diabetes: lack of evidence versus lack of action. Expert Opin Pharmacother 2021;:1-3. [PMID: 34165014 DOI: 10.1080/14656566.2021.1942842] [Reference Citation Analysis]